Original ResearchAdherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance
References (25)
- et al.
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
Diabetes Res Clin Pract
(1995) - et al.
Cost-effectiveness of intensive insulin therapy for type 2 diabetes: A 10-year follow-up ofthe Kumamoto study
Diabetes Res Clin Pract
(2000) - et al.
Patient compliance and persistence with antihyperglycemic drug regimens: Evaluation of a Medicaid patient population with type 2 diabetes mellitus
Clin Ther
(2001) - et al.
The effects of initial drug choice and comorbidityon antihypertensive therapy compliance: Results from a population-based study in the elderly
Am J Hypertens
(1997) - et al.
Appropriate reductions in compliance among well-controlled hypertensive patients
J Clin Epidemiol
(1991) - et al.
Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus
Clin Ther.
(1999) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
(1998)- et al.
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients
Diabetes Care
(2000) - et al.
Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial
JAMA
(1998) - et al.
for the American Diabetes Association. Implications of the United Kingdom prospective diabetes study
Diabetes Care
(2003)
Utilization of oral hypoglycemic agents in a drug-insured US population
Diabetes Care
(2001)
Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: A retrospective cohort study
Diabet Med
(2002)
Cited by (153)
Determinants of preventable stroke—Ankara ACROSS stroke preventability study
2020, Journal of Stroke and Cerebrovascular DiseasesPersistence of newer anti-obesity medications in a real-world setting
2018, Diabetes Research and Clinical PracticeExercise and Diabetes: A Narrative Review
2017, Journal of Foot and Ankle SurgeryCitation Excerpt :Additionally, Mu et al (32) reported that only 12% of persons with DM met the ADA standard for resistance exercise, a value 9% less than that for the general population. Even if a satisfactory exercise program has been recommended by a health care provider, nonadherence to participation in exercise has been considerable, ranging from 35% to 86% (33–39). Other components of the treatment recommendation fared better than exercise regarding patient compliance.
Making medications stick: Improving medication adherence by highlighting the personal health costs of non-compliance
2021, Behavioural Public Policy
Copyright © 2005 Published by Elsevier Inc.